WESTFORD, Mass., May 15 Cynosure, Inc.(Nasdaq: CYNO), a leading developer and manufacturer of a broad array oflight-based aesthetic treatment systems, today announced that its seniormanagement will present at the 2008 Citi Investment Research Global HealthCare Conference, taking place at the Hilton New York.
Cynosure's presentation will be webcast live over the Internet beginningat 2:00 p.m. (ET) Thursday, May 22, 2008. President and Chief ExecutiveOfficer Michael Davin and Chief Financial Officer Timothy Baker plan todiscuss Cynosure's business outlook, growth strategy and recent financialresults. To access the live or archived webcast, visit the "InvestorRelations" portion of Cynosure's website at www.cynosure.com.
About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems that areused by physicians and other practitioners to perform non-invasive andminimally invasive procedures to remove hair, treat vascular lesions,rejuvenate skin through the treatment of shallow vascular and pigmentedlesions, laser lipolysis and temporarily reduce the appearance of cellulite.Cynosure's products include a broad range of laser and other light-basedenergy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, aswell as intense pulsed light. Cynosure was founded in 1991. For corporate orproduct information, contact Cynosure at 800-886-2966, or visithttp://www.cynosure.com.Contact: Scott Solomon Vice President Sharon Merrill Associates, Inc. 617.542.5300 [email protected]
SOURCE Cynosure, Inc.